Publicité
Publicité

CELZ

CELZ logo

Creative Medical Technology Holdings, Inc. Common Stock

2.27
USD
Sponsorisé
-0.18
-7.35%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

2.31

+0.04
+1.98%

CELZ Rapports sur les bénéfices

Ratio de surprise positive

CELZ a dépassé 7 des 16 dernières estimations.

44%

Prochain rapport

Date du prochain rapport
12 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.37
Variation implicite de Q3 25 (Revenue/ EPS)
--
/
-22.92%
Variation implicite de Q4 24 (Revenue/ EPS)
-100.00%
/
-66.96%

Creative Medical Technology Holdings, Inc. Common Stock earnings per share and revenue

On 07 nov. 2025, CELZ reported earnings of -0.48 USD per share (EPS) for Q3 25, beating the estimate of -0.48 USD, resulting in a 1.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.37 USD, with revenue projected to reach -- USD, implying an baisse of -22.92% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Creative Medical Technology Holdings, Inc. Common Stock reported EPS of -$0.48, beating estimates by 1.96%, and revenue of $0.00, 0% as expectations.
The stock price moved up 8.61%, changed from $3.02 before the earnings release to $3.28 the day after.
The next earning report is scheduled for 12 mars 2026.
Based on 3 analystes, Creative Medical Technology Holdings, Inc. Common Stock is expected to report EPS of -$0.37 and revenue of -- for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité